| Oct 29 |
OTC Markets Hosts Virtual Investor Presentation with Prashant Kohli, CEO of Grace Therapeutics (Acasti Pharma), with John Vandermosten, Senior Analyst at Zacks SCR
|
| Oct 25 |
Acasti Pharma changes name to Grace Therapeutics
|
| Oct 25 |
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
|
| Sep 25 |
Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
|
| Sep 20 |
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
|
| Sep 16 |
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
|
| Sep 5 |
Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 9 |
Acasti Pharma GAAP EPS of -$0.24
|
| Aug 9 |
Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update
|
| Jul 10 |
Is Acasti Pharma (ACST) Outperforming Other Medical Stocks This Year?
|
